Actinic granuloma

LAST UPDATED: Feb 22, 2024

Introduction

Actinic granuloma is a rare, idiopathic disorder of middle-aged adults that always appears on UV-exposed skin. It is a form of granulomatous dermatosis characterised by annular plaques with central atrophy and raised erythematous margins that are similar to those observed in granuloma annulare. 

There is debate around whether actinic granuloma is a variant of annular elastolytic giant cell granuloma that only affects the face, or a different entity. 


Aetiology

  • Although the pathogenesis is unknown, the most accepted theory is that it is a granulomatous reaction induced by an antigenic agent present in the elastic fibres affected by the sun exposition

History

  • Predominantly affects middle-aged individuals and has a female predilection

Clinical findings

  • Actinic granuloma presents with small papules that quickly evolve into annular plaques with a gradually expanding border. The centre has a pale atrophic appearance

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Investigations

  • The lesions are histopathologically similar to granuloma annulare and show non-palisading granulomas with foreign-body-type, multinucleated giant cells as well as lymphocytes and histiocytes. The lymphocytes are predominantly CD4 positive. The histopathologic criteria that distinguish actinic granuloma from granuloma annulare are the absence of elastic fibres in the centre of the actinic granuloma lesions and the presence of elastic fibres within giant cells. Additionally, there should not be any increase in mucin, which might be expected in granuloma annulare

Management

  • UV-protection aims to reduce the development of further lesions
  • There is no reliably effective treatment. Infiltration of corticosteroids into the raised edge, phototherapy, and antimalarials antimalarials are largely ineffective
  • Some patients experience spontaneous resolution

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco